Antiretroviral Therapy Regimens for Neuro-AIDS
Journal:
Current Drug Targets - Infectious Disorders
Volume:
2
Page:
187-192
Author(s):
G. Arendt and H. J. von Giesen
Inflammation and Parkinsons Disease
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
221-242
Author(s):
Christophe Wersinger and Anita Sidhu
In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
203-209
Author(s):
A(Bert). G. de Boer and P. J. Gaillard
Targeting Neuronal Nicotinic Receptors: a Path to New Therapies
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
349-357
Author(s):
Merouane Bencherif and Jeffrey D. Schmitt
Human Brain Nicotinic Receptors, their Distribution and Participation in Neuropsychiatric Disorders
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
387-397
Author(s):
A. J. Graham, C. M. Martin-Ruiz, T. Teaktong, M. A. Ray and J. A. Court
The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
399-411
Author(s):
M. J. O'Neill, T. K. Murray, V. Lakics, N. P. Visanji and S. Duty
Current and Future Therapeutic Strategies to Target Inflammation in Stroke
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
151-166
Author(s):
Wandong Zhang and Danica Stanimirovic
Toll-Like Receptors and Inflammation in the CNS
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
181-191
Author(s):
Sung Joong Lee and Soojin Lee
Cytokines in Dementias
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
193-200
Author(s):
Elisabeth Tarkowski
Preface
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
i-i
Author(s):
Gregory S. Hamilton